North China Pharmaceutical’s Ormutivimab Approved for Pediatric Use in China
North China Pharmaceutical Group Corporation (SHA: 600812) has announced that it has received approval from...
HutchMed’s Sovleplenib Phase III Results to be Showcased at EHA 2024
HutchMed (China) Ltd (NASDAQ: HCM, HKG: 0013), a biopharmaceutical company based in China, is preparing...
Shanghai UniCAR-Therapy’s Innovative CAR-T Therapy Targets Breakthrough Designation with IL-6 Silencing
Shanghai UniCAR-Therapy Bio-Medicine Technology Co., Ltd, a leading biopharmaceutical company based in China, is on...
Sol-Gel Technologies Partners with Shenzhen Beimei for Twyneo Commercialization in China
Israel-based dermatology specialist Sol-Gel Technologies Ltd. (NASDAQ: SLGL) has announced the signing of a licensing...
J&J Acquires Immune-Mediated Diseases Specialist Proteologix in a Deal Worth Up to USD 850 Million
Johnson & Johnson (J&J; NYSE: JNJ), a global healthcare giant, has announced a deal to...
China’s Health Commission Boosts Efforts to Monitor and Respond to Drug Shortages
The National Health Commission (NHC) of China has recently announced the reinforcement of national and...
Huaixi Medical and Beijing HumaDX Tech Join Forces to Boost In Vitro Diagnostics
Huaixi Medical, a Nanjing-based specialist in flow cytometry, has entered into a strategic partnership with...
Bayer’s 225Ac-PSMA-Trillium Therapy Begins Early-Stage Clinical Trial for mCRPC
Bayer AG (ETR: BAYN), a multinational pharmaceutical company based in Germany, has this week commenced...
Merck KGaA Subsidiary Teams Up with Aulos Bioscience to Test PD-L1 and Anti-IL-2 Combination
Germany’s Merck KGaA (ETR: MRK) has announced that its Switzerland-based subsidiary, Ares Trading, has entered...
Chunlizhengda’s Handheld Orthopedic Robot Approved by China’s NMPA
Beijing Chunlizhengda Medical Instruments Co., Ltd (HKG: 1858, SHA: 688236) has received marketing approval from...
Roche Marks 30 Years in China with Commitment to Boost Investments and Local Manufacturing
Roche (SWX: ROG), the Swiss pharmaceutical giant, has reaffirmed its long-term commitment to the Chinese...
Hengrui Pharmaceuticals Strikes Deal with Hercules CM Newco to Supply GLP-1 Products for Global Markets
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading Chinese pharmaceutical company, has entered into...
Roc Rock Biotechnology Secures Ethical Approval for CAR-M Therapy in Ovarian Cancer
China-based Roc Rock Biotechnology Co., Ltd. has announced that it has received ethical approval from...
Landmark Biosecure Act Passes US House Committee with 40-1 Vote, Eyes 2024 Enactment
The US House Committee on Oversight and Accountability has completed the markup process for amendments...
Novo Holdings Gains Controlling Interest in Biopharma Equipment Supplier Single Use Support
Novo Nordisk’s (CPH: NOVO-B) controlling shareholder, Novo Holdings, has entered into an agreement to purchase...
AstraZeneca and BenevolentAI Reach Milestone in Heart Failure Target Validation
AstraZeneca (AZ; NASDAQ: AZN) has announced the successful experimental validation of a groundbreaking heart failure...
Sunho Biologics Lists on HKEX with HKD 461 Million Biotech IPO
Sunho Biologics, Inc., (HKG: 2898) a clinical-stage biopharmaceutical company based in China specializing in biologic...
Lifetech Scientific’s IBS Stent Demonstrates Non-Inferiority in Phase II Trial
Lifetech Scientific Corporation (HKG: 1302), a biopharmaceutical company based in China, has announced the completion...
Olymvax Biopharmaceuticals Gets Green Light for Tetravalent Influenza Vaccine Clinical Trial
Olymvax Biopharmaceuticals Inc. (SHA: 688319), a leading vaccine specialist headquartered in Chengdu, China, has announced...
Insilico Medicine’s ISM8207 Enters Phase I Clinical Trial for Lymphoma and Solid Tumors
China’s generative artificial intelligence (AI)-driven biotech firm, Insilico Medicine, has announced the first patient dosing...